Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BioArctic | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 15.93B | -68.4x | 0.36 | SEK 180.30 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medivir B | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 3.65B | -0.09 | SEK 2.70 | -4.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
BioInvent International | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 2.72B | -6.6x | 0.23 | SEK 41.50 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Egetis Therapeutics AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 2.40B | -6x | -0.33 | SEK 6.68 | 6.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hansa Biopharma | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 2.06B | -2.7x | -0.1 | SEK 30.34 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Devyser Diagnostics AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 2.05B | -30.8x | 1.25 | SEK 122 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 23.9% Upside | Upgrade to Pro+ | |
Vicore Pharma Holding AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.81B | -4.4x | -0.22 | SEK 7.72 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Diamyd Medical | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.61B | -9.6x | 1.27 | SEK 15.44 | -2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cereno Scientific | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.58B | -21.3x | 0.41 | SEK 5.64 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
XSpray Pharma | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.54B | -5.7x | 1.21 | SEK 45.30 | 3.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nanoform Finland Plc | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.32B | -4.9x | 1.7 | SEK 15.18 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Intellego Technologies AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.19B | 13.8x | 0.16 | SEK 42.40 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nykode Therapeutics | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 916.33M | -1.9x | SEK 13.98 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Saniona AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 728.37M | -7.5x | -0.35 | SEK 6.53 | -3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -10.8% Downside | Upgrade to Pro+ | |
Hamlet Pharma AB | Spotlight | Healthcare | Biotechnology & Medical Research | SEK 575.43M | -14.2x | 0.74 | SEK 3.39 | -5.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Promimic AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 513.08M | -48.5x | 2.66 | SEK 26.40 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Mendus AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 424.13M | -3x | -0.06 | SEK 8.93 | 6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SynAct Pharma AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 419.16M | -2.1x | -0.14 | SEK 10.92 | 10.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Initiator Pharma | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 393.71M | -23.2x | -0.39 | SEK 7 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Curasight AS | Spotlight | Healthcare | Biotechnology & Medical Research | SEK 374.75M | -7.2x | 0.51 | SEK 15.78 | -6.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Peptonic Medical | Spotlight | Healthcare | Biotechnology & Medical Research | SEK 345.56M | -0.4x | -0.01 | SEK 0.004 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Oncopeptides | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 339.56M | -0.8x | -0.04 | SEK 1.58 | 2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Alzinova | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 337.05M | -11.2x | -0.75 | SEK 3.78 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cantargia AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 328.80M | -1.7x | -0.04 | SEK 1.79 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ascelia Pharma | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 307.54M | -1.6x | -0.07 | SEK 3.15 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Xbrane Biopharma | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 275.31M | -0.4x | -0.01 | SEK 0.18 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Guard Therapeutics | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 245.90M | -2.4x | -0.07 | SEK 20 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Biovica International | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 245.29M | -1.6x | -0.05 | SEK 2.65 | -3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Alligator Bioscience | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 238.02M | -0.9x | -0.02 | SEK 0.31 | 26.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Annexin Pharma | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 229.71M | -3x | -0.11 | SEK 0.43 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |